<DOC>
	<DOCNO>NCT00863525</DOCNO>
	<brief_summary>This study ass safety tolerability single dos odanacatib ( MK0822 ) administer light breakfast .</brief_summary>
	<brief_title>A Study Assess Effects Light Breakfast Safety , Tolerability , Pharmacokinetics Odanacatib ( MK0822 )</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<criteria>Subject male age 18 45 Subject within 25 % ideal body weight weigh 55 95 kg Subject generally good health Subject nonsmoker Subject multiple severe allergy food medication Subject history metabolic bone disease , kidney/bladder stone , treatment bisphosphonates Subject infection , include HIV Subject donate blood take another investigational drug last month Subject consume excessive amount caffeine alcohol Subject history illness may confound result study pose additional risk administer study drug</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>